Literature DB >> 8175770

Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with polyethylene glycol in a site-specific manner.

I Benhar1, Q C Wang, D FitzGerald, I Pastan.   

Abstract

Pseudomonas exotoxin A (PE) is composed of three structural and functional domains. Domain Ia is responsible for cell recognition, domain II for translocation of PE across the cell membrane, and domain III for ADP-ribosylation of elongation factor 2. To investigate the role of the amino acids exposed on the surface of domain III, we replaced 15 of these, generating 29 different mutants at positions 412, 416, 418, 490, 513, 516, 522, 551, 576, 590, 599, 604, 606, 607 and 608. All but one mutant retained substantial ADP-ribosylation and cytotoxic activities. Modification of proteins with monomethoxy-polyethylene glycol (mPEG) prolongs their circulation in the blood stream and reduces their immunogenicity. Unlike PEGylated enzymes acting on small molecule substrates, PEGylated toxins may lose those functions that are based on macromolecular interactions. Therefore, we selectively PEGylated mutant PEs at positions 490, 513, 516, 522, 604, and 606. Most PEs modified by a 5-kDa mPEG via a disulfide or a thioether bond retained high cytotoxic activity. However, when a 20-kDa mPEG was used there was a decrease in cytotoxic activity with the disulfide-bonded molecules being more active. Positions 522 and 604 are good sites for PEGylation, but 490 is not. We also found that PEGylation of PE 522C prolonged its in vivo circulation time in mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  11 in total

1.  Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.

Authors:  Y Tsutsumi; M Onda; S Nagata; B Lee; R J Kreitman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Fingerprinting proteins coupled with polymers by mass spectrometry: Investigation of polyethylene glycol-conjugated superoxide dismutase.

Authors:  S K Chowdhury; M Doleman; D Johnston
Journal:  J Am Soc Mass Spectrom       Date:  1995-06       Impact factor: 3.109

Review 3.  Immunogenicity of therapeutic recombinant immunotoxins.

Authors:  Ronit Mazor; Masanori Onda; Ira Pastan
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 10.983

Review 4.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

5.  Synthetic Cells Synthesize Therapeutic Proteins inside Tumors.

Authors:  Nitzan Krinsky; Maya Kaduri; Assaf Zinger; Janna Shainsky-Roitman; Mor Goldfeder; Itai Benhar; Dov Hershkovitz; Avi Schroeder
Journal:  Adv Healthc Mater       Date:  2017-12-28       Impact factor: 11.092

6.  The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.

Authors:  M Li; F Dyda; I Benhar; I Pastan; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 12.779

7.  Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin.

Authors:  D M Roscoe; S H Jung; I Benhar; L Pai; B K Lee; I Pastan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.609

8.  Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.

Authors:  I Benhar; E A Padlan; S H Jung; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 12.779

9.  A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis.

Authors:  Nitzan Krinsky; Maya Kaduri; Janna Shainsky-Roitman; Mor Goldfeder; Eran Ivanir; Itai Benhar; Yuval Shoham; Avi Schroeder
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

Review 10.  Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.

Authors:  Yehudit Grinberg; Itai Benhar
Journal:  Biomedicines       Date:  2017-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.